Elevance Health (ELV) Interest Expenses (2009 - 2026)

Elevance Health (ELV) has 18 years of Interest Expenses data on file, last reported at $357.0 million in Q1 2026.

• Quarterly Interest Expenses rose 3.78% year-over-year to $357.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 11.95% YoY) and the FY2025 annual result came in at $1.4 billion, up 18.31% from the prior year.
• Interest Expenses slipped to $357.0 million in Q1 2026 per ELV's latest filing, from $366.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $366.0 million in Q4 2025 and bottomed at $201.0 million in Q1 2022.
• The 5-year median for Interest Expenses is $265.0 million (2024), against an average of $283.8 million.
• The widest annual swing landed in 2022, when Interest Expenses advanced 1.46%; it then soared 31.27% in 2024.
• Tracing ELV's Interest Expenses over 5 years: stood at $229.0 million in 2022, then advanced by 13.1% to $259.0 million in 2023, then surged by 31.27% to $340.0 million in 2024, then increased by 7.65% to $366.0 million in 2025, then retreated by 2.46% to $357.0 million in 2026.
• Per Business Quant, the three latest ELV Interest Expenses figures stand at $357.0 million (Q1 2026), $366.0 million (Q4 2025), and $351.0 million (Q3 2025).

Peer Comparison